EGFR and neoplasm: The PDAC‐related markers CA19‐9, CEA, EGFR, Ki67, and HER2 in the organoid tissues were consistent with those of patient tumor tissues, suggesting that these two PDO models better maintained the clinical characteristics of primary tumors.